Loading...
XSTOCRADb
Market cap86mUSD
Dec 23, Last price  
29.30SEK
1D
-1.51%
1Q
-21.45%
Jan 2017
143.15%
IPO
53.40%
Name

C Rad AB

Chart & Performance

D1W1MN
XSTO:CRADb chart
P/E
27.14
P/S
2.27
EPS
1.08
Div Yield, %
0.00%
Shrs. gr., 5y
1.76%
Rev. gr., 5y
17.44%
Revenues
425m
+40.92%
1,291,1244,898,74914,234,44614,909,75525,775,90545,036,18453,191,61366,160,75182,653,556133,125,000190,110,000205,394,000221,628,000261,152,000301,326,000424,615,000
Net income
36m
+375.05%
-10,722,785-10,250,579-9,838,118-42,606,182-19,388,657-20,994,730-6,298,477-21,183,842-31,209,176-10,907,00021,191,000-13,800,00014,365,00025,102,0007,479,00035,529,000
CFO
33m
+244.51%
-10,055,732-8,726,049-5,014,115-20,426,509-13,063,389-22,856,329-16,611,834-22,951,019-44,623,107-4,020,000-9,606,00015,827,00018,447,00018,168,0009,690,00033,383,000
Earnings
Feb 07, 2025

Profile

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
IPO date
Jul 23, 2007
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
424,615
40.92%
301,326
15.38%
261,152
17.83%
Cost of revenue
141,653
100,547
147,225
Unusual Expense (Income)
NOPBT
282,962
200,779
113,927
NOPBT Margin
66.64%
66.63%
43.62%
Operating Taxes
8,397
14,006
10,637
Tax Rate
2.97%
6.98%
9.34%
NOPAT
274,565
186,773
103,290
Net income
35,529
375.05%
7,479
-70.21%
25,102
74.74%
Dividends
Dividend yield
Proceeds from repurchase of equity
(2,292)
1,004
4,224
BB yield
0.16%
-0.08%
-0.22%
Debt
Debt current
(18,973)
(14,645)
Long-term debt
3,506
8,152
12,748
Deferred revenue
Other long-term liabilities
(1,000)
Net debt
(125,855)
(143,033)
(138,012)
Cash flow
Cash from operating activities
33,383
9,690
18,168
CAPEX
(4,106)
(11,222)
(5,798)
Cash from investing activities
(16,931)
(11,222)
(5,798)
Cash from financing activities
(5,690)
(2,384)
1,045
FCF
245,117
173,330
75,314
Balance
Cash
129,361
121,896
122,420
Long term investments
10,316
13,695
Excess cash
108,130
117,146
123,057
Stockholders' equity
(105,034)
(138,914)
(148,044)
Invested Capital
377,967
366,560
370,863
ROIC
73.76%
50.66%
28.06%
ROCE
103.67%
88.20%
51.13%
EV
Common stock shares outstanding
33,767
33,764
33,934
Price
42.20
10.76%
38.10
-31.60%
55.70
15.56%
Market cap
1,424,965
10.77%
1,286,409
-31.94%
1,890,118
17.78%
EV
1,299,110
1,143,376
1,753,427
EBITDA
291,823
210,891
123,634
EV/EBITDA
4.45
5.42
14.18
Interest
379
416
169
Interest/NOPBT
0.13%
0.21%
0.15%